Crescita Therapeutics Inc. (CTX.TO)
CAD 0.57
(1.79%)
CAD 0.57
(1.79%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 6.12 Million CAD | 8.48% |
| 2022 | 5.64 Million CAD | 28.55% |
| 2021 | 4.39 Million CAD | 27.05% |
| 2020 | 3.45 Million CAD | -8.64% |
| 2019 | 3.78 Million CAD | 40.25% |
| 2018 | 2.69 Million CAD | -14.76% |
| 2017 | 3.16 Million CAD | 6.14% |
| 2016 | 2.98 Million CAD | 697.33% |
| 2015 | 374 Thousand CAD | -10.53% |
| 2014 | 418 Thousand CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 5.26 Million CAD | 4.15% |
| 2024 Q1 | 5.05 Million CAD | -17.4% |
| 2023 FY | 6.12 Million CAD | 8.48% |
| 2023 Q1 | 5.45 Million CAD | -3.4% |
| 2023 Q2 | 5.32 Million CAD | -2.35% |
| 2023 Q3 | 5.88 Million CAD | 10.57% |
| 2023 Q4 | 6.12 Million CAD | 4.01% |
| 2022 Q3 | 4.99 Million CAD | 1.16% |
| 2022 Q1 | 4.95 Million CAD | 12.82% |
| 2022 FY | 5.64 Million CAD | 28.55% |
| 2022 Q2 | 4.93 Million CAD | -0.42% |
| 2022 Q4 | 5.64 Million CAD | 13.12% |
| 2021 Q1 | 3.53 Million CAD | 2.17% |
| 2021 Q4 | 4.39 Million CAD | -8.8% |
| 2021 Q3 | 4.81 Million CAD | 22.42% |
| 2021 Q2 | 3.93 Million CAD | 11.38% |
| 2021 FY | 4.39 Million CAD | 27.05% |
| 2020 Q2 | 4.01 Million CAD | 6.19% |
| 2020 Q1 | 3.78 Million CAD | -0.11% |
| 2020 Q4 | 3.45 Million CAD | -10.49% |
| 2020 Q3 | 3.86 Million CAD | -3.79% |
| 2020 FY | 3.45 Million CAD | -8.64% |
| 2019 Q4 | 3.78 Million CAD | -10.29% |
| 2019 Q2 | 3.74 Million CAD | 23.17% |
| 2019 FY | 3.78 Million CAD | 40.25% |
| 2019 Q1 | 3.03 Million CAD | 12.6% |
| 2019 Q3 | 4.21 Million CAD | 12.72% |
| 2018 Q1 | 3.27 Million CAD | 3.48% |
| 2018 FY | 2.69 Million CAD | -14.76% |
| 2018 Q4 | 2.69 Million CAD | -7.6% |
| 2018 Q3 | 2.92 Million CAD | -3.63% |
| 2018 Q2 | 3.03 Million CAD | -7.48% |
| 2017 Q3 | 4.06 Million CAD | -3.35% |
| 2017 Q2 | 4.2 Million CAD | -2.73% |
| 2017 FY | 3.16 Million CAD | 6.14% |
| 2017 Q1 | 4.32 Million CAD | 44.97% |
| 2017 Q4 | 3.16 Million CAD | -22.12% |
| 2016 Q1 | 57 Thousand CAD | -84.76% |
| 2016 Q4 | 2.98 Million CAD | -9.58% |
| 2016 Q3 | 3.29 Million CAD | 9061.11% |
| 2016 Q2 | 36 Thousand CAD | -36.84% |
| 2016 FY | 2.98 Million CAD | 697.33% |
| 2015 FY | 374 Thousand CAD | -10.53% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q4 | 374 Thousand CAD | 0.0% |
| 2014 FY | 418 Thousand CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aurora Cannabis Inc. | 186.37 Million CAD | 96.714% |
| Avicanna Inc. | 4.54 Million CAD | -34.786% |
| Avant Brands Inc. | 28.93 Million CAD | 78.833% |
| Cardiol Therapeutics Inc. | -279.87 Thousand CAD | 2288.5% |
| Knight Therapeutics Inc. | 91.83 Million CAD | 93.33% |
| MediPharm Labs Corp. | 9.89 Million CAD | 38.125% |
| OrganiGram Holdings Inc. | 80.95 Million CAD | 92.434% |
| Canopy Growth Corporation | 77.29 Million CAD | 92.076% |
| Willow Biosciences Inc. | 221 Thousand CAD | -2671.493% |
| Auxly Cannabis Group Inc. | 31.42 Million CAD | 80.512% |